(UIMA) UBS SICAV - MSCI Europe - Ratings and Ratios

Exchange: XETRA • Country: Germany • Currency: EUR • Type: Etf • ISIN: LU0446734104 • Europe Large-Cap Blend Equity

UIMA: Stocks, Bonds, European, Equities

The UBS ETF SICAV - MSCI Europe UCITS ETF (Ticker: UIMA) is a Germany-domiciled exchange-traded fund listed on Xetra. It tracks the Morningstar DM Eur TME Nr EUR Index, providing exposure to large-cap equity securities across European developed markets. The fund is designed for investors seeking diversified exposure to European large-cap companies, offering a blend of value and growth opportunities.

From a technical perspective, the ETFs price action reflects a bullish short-term trend. The last price of 91.76 EUR is above its 20-day SMA of 90.34 and 50-day SMA of 87.07, indicating recent upward momentum. The 200-day SMA of 84.79 suggests a longer-term bullish trend. The average trading volume over the past 20 days is 1,129 shares, indicating moderate liquidity. The ATR of 0.65 reflects relatively low volatility in recent price movements.

In terms of fundamental analysis, the ETF has an AUM of 240.73 million EUR, making it a mid-sized fund in its category. The funds holdings are diversified across sectors, including financials, industrials, and consumer discretionary, aligning with the broader European large-cap equity market composition.

Over the next three months, the ETF is expected to maintain its upward trajectory, supported by the 20-day SMA acting as a support level. If the price breaks above the resistance zone near 94.00, further upside to 96.00 is possible. However, a pullback to the 50-day SMA at 87.07 could act as a buying opportunity. Key support levels are at 89.00 and 84.79, corresponding to the 50-day and 200-day SMAs, respectively. Fundamentally, the ETFs performance will likely be influenced by the macroeconomic environment in Europe. With inflation concerns easing and interest rates stabilizing, sectors such as energy and utilities may outperform. However, consumer discretionary and technology sectors could face headwinds due to slower economic growth expectations. The funds diversified exposure reduces sector-specific risks, making it a stable choice for investors seeking European equity exposure.

Additional Sources for UIMA ETF

Tweets: X Stocktwits
Fund Manager Positions: Dataroma Stockcircle

UIMA ETF Overview

Market Cap in USD 260m
Category Europe Large-Cap Blend Equity
TER 0.10%
IPO / Inception 2009-10-05

UIMA ETF Ratings

Growth 5y 75.0%
Fundamental -
Dividend 54.9%
Rel. Strength -0.2
Analysts -
Fair Price Momentum 91.69 EUR
Fair Price DCF -

UIMA Dividends

Dividend Yield 12m 2.71%
Yield on Cost 5y 5.05%
Annual Growth 5y 10.63%
Payout Consistency 93.7%

UIMA Growth Ratios

Growth Correlation 3m 68.1%
Growth Correlation 12m 58.1%
Growth Correlation 5y 91.6%
CAGR 5y 13.66%
CAGR/Max DD 5y 0.70
Sharpe Ratio 12m 1.03
Alpha 2.04
Beta 0.503
Volatility 12.30%
Current Volume 2.1k
Average Volume 20d 1.8k
What is the price of UIMA stocks?
As of April 03, 2025, the stock is trading at EUR 88.68 with a total of 2,094 shares traded.
Over the past week, the price has changed by -2.02%, over one month by -4.46%, over three months by +5.90% and over the past year by +8.67%.
Is UBS SICAV - MSCI Europe a good stock to buy?
Yes. Based on ValueRay Analyses, UBS SICAV - MSCI Europe (XETRA:UIMA) is currently (April 2025) a good stock to buy. It has a ValueRay Growth Rating of 75.00 and therefor a clear technical positive rating according to historical growth.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of UIMA as of April 2025 is 91.69. This means that UIMA is currently overvalued and has a potential downside of 3.39%.
Is UIMA a buy, sell or hold?
UBS SICAV - MSCI Europe has no consensus analysts rating.
What are the forecast for UIMA stock price target?
According to ValueRays Forecast Model, UIMA UBS SICAV - MSCI Europe will be worth about 101.2 in April 2026. The stock is currently trading at 88.68. This means that the stock has a potential upside of +14.1%.
Issuer Forecast Upside
Wallstreet Target Price - -
Analysts Target Price - -
ValueRay Target Price 101.2 14.1%